Literature DB >> 16388320

Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.

Senija Behrem1, Kamelija Zarković, Neven Eskinja, Nives Jonjić.   

Abstract

Tenascin-C (TN-C) is an extracellular matrix protein which participates in different processes like normal fetal development, wound healing, inflammation, keloids and rheumatoid arthritis. Furthermore, the immunostaining for TN-C is seen in the stroma of various malignant tumors as in glioblastoma multiforme (GBM), however, the significance of these findings is still not clear. In this study 62 GBM samples were analyzed immunohistochemically for distribution patterns of TN-C and correlated with angiogenesis and tumor cell proliferation. Tenascin-C in GBM localizes in two compartments, perivascular and intercellular space. Intercellular tenascin-C (TN-C ic) showed focal distribution in 66%, and diffuse one in 34% of cases. Perivascular tenascin-C (TN-C pv) showed strong correlation with microvascular density (MVD) and vascular endothelial growth factor (VEGF) expression. Moreover, it seems that TN-C pv enhanced the effect of VEGF. Intercellular TN-C did not correlate with MVD and VEGF expression, but showed strong correlation with proliferation index. Furthermore, tumors with diffuse TN-C ic expression had higher proliferation indices than tumors with focal TN-C expression. Our results indicate that TN-C plays a role in angiogenesis and tumor cell proliferation, but beside the intensity of expression, the distribution patterns are also important in these processes. This study also suggests that perivascular and intercellular TN-C compartments have probably different sources and different roles in GBM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388320     DOI: 10.1007/BF02893856

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

1.  Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts.

Authors:  K L Crossin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.

Authors:  C H Kim; K H Bak; Y S Kim; J M Kim; Y Ko; S J Oh; K M Kim; E K Hong
Journal:  Surg Neurol       Date:  2000-09

Review 3.  The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.

Authors:  F S Jones; P L Jones
Journal:  Dev Dyn       Date:  2000-06       Impact factor: 3.780

4.  Clinical impact and functional aspects of tenascin-C expression during glioma progression.

Authors:  Christel Herold-Mende; Margareta M Mueller; Mario M Bonsanto; Horst Peter Schmitt; Stefan Kunze; Hans-Herbert Steiner
Journal:  Int J Cancer       Date:  2002-03-20       Impact factor: 7.396

5.  Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

Authors:  M Higuchi; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Tenascin expression in human glioma cell lines and normal tissues.

Authors:  J B Ventimiglia; C J Wikstrand; L E Ostrowski; M A Bourdon; V A Lightner; D D Bigner
Journal:  J Neuroimmunol       Date:  1992-01       Impact factor: 3.478

7.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

8.  Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.

Authors:  Keiichiro Tanaka; Noriko Hiraiwa; Hisashi Hashimoto; Yoji Yamazaki; Moriaki Kusakabe
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

9.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth.

Authors:  D Fischer; M Brown-Lüdi; T Schulthess; R Chiquet-Ehrismann
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

10.  Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins.

Authors:  A Giese; M A Loo; S A Norman; S Treasurywala; M E Berens
Journal:  J Cell Sci       Date:  1996-08       Impact factor: 5.285

View more
  19 in total

1.  A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.

Authors:  Dana A M Mustafa; Lennard J Dekker; Christoph Stingl; Andreas Kremer; Marcel Stoop; Peter A E Sillevis Smitt; Johan M Kros; Theo M Luider
Journal:  Mol Cell Proteomics       Date:  2012-01-25       Impact factor: 5.911

Review 2.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

3.  Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.

Authors:  Maxime S Heroux; Marla A Chesnik; Brian D Halligan; Mona Al-Gizawiy; Jennifer M Connelly; Wade M Mueller; Scott D Rand; Elizabeth J Cochran; Peter S LaViolette; Mark G Malkin; Kathleen M Schmainda; Shama P Mirza
Journal:  Physiol Genomics       Date:  2014-05-06       Impact factor: 3.107

Review 4.  Passive immunotherapeutic strategies for the treatment of malignant gliomas.

Authors:  Daniel T Nagasawa; Christina Fong; Andrew Yew; Marko Spasic; Heather M Garcia; Carol A Kruse; Isaac Yang
Journal:  Neurosurg Clin N Am       Date:  2012-07       Impact factor: 2.509

5.  Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.

Authors:  Shuli Xia; Bachchu Lal; Brian Tung; Shervin Wang; C Rory Goodwin; John Laterra
Journal:  Neuro Oncol       Date:  2015-08-27       Impact factor: 12.300

6.  Laminin alpha 2 enables glioblastoma stem cell growth.

Authors:  Justin D Lathia; Meizhang Li; Peter E Hall; Joseph Gallagher; James S Hale; Qiulian Wu; Monica Venere; Emily Levy; M R Sandhya Rani; Ping Huang; Eunnyung Bae; Julia Selfridge; Lin Cheng; Hacer Guvenc; Roger E McLendon; Ichiro Nakano; Andrew E Sloan; Heidi S Phillips; Albert Lai; Candece L Gladson; Markus Bredel; Shideng Bao; Anita B Hjelmeland; Jeremy N Rich
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

7.  Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Authors:  Omar Dzaye; Feng Hu; Katja Derkow; Verena Haage; Philipp Euskirchen; Christoph Harms; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-30       Impact factor: 3.685

8.  Identification of proteins with potential osteogenic activity present in the water-soluble matrix proteins from Crassostrea gigas nacre using a proteomic approach.

Authors:  Daniel V Oliveira; Tomé S Silva; Odete D Cordeiro; Sofia I Cavaco; Dina C Simes
Journal:  ScientificWorldJournal       Date:  2012-05-01

9.  Nucleic acids in human glioma treatment: innovative approaches and recent results.

Authors:  S Catuogno; C L Esposito; C Quintavalle; G Condorelli; V de Franciscis; L Cerchia
Journal:  J Signal Transduct       Date:  2012-05-21

10.  Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.

Authors:  Song Nie; Mikel Gurrea; Jianhui Zhu; Smathorn Thakolwiboon; Jason A Heth; Karin M Muraszko; Xing Fan; David M Lubman
Journal:  J Proteome Res       Date:  2014-12-12       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.